Table 2.
Variable | Categories | Bouts per Day | Minutes per Bout* | METs per Minute* | Total MET-minutes* |
---|---|---|---|---|---|
BMI | 25.0 to <27.0 kg/m2 | 0.79 ± 1.21 (N=46) | 20.74 ± 10.29 (N=35) | 5.14 ± 1.11 (N=35) | 113.9 ± 87.09 (N=35) |
27.0 to <30.0 kg/m2 | 0.72 ± 0.79 (N=235) | 22.21 ± 10.81 (N=172) | 5.36 ± 1.16 (N=172) | 125.3 ± 81.98 (N=172) | |
30.0 to <35.0 kg/m2 | 0.65 ± 0.90 (N=719) | 21.09 ± 10.06 (N=522) | 5.25 ± 1.00 (N=521) | 115.1 ± 71.58 (N=521) | |
35.0 to <40.0 kg/m2 | 0.59 ± 0.78 (N=619) | 18.79 ± 9.05 (N=448) | 5.11 ± 1.02 (N=448) | 100.0 ± 67.42 (N=448) | |
≥40 kg/m2 | 0.52 ± 0.95 (N=525) | 17.02 ± 7.51 (N=346) | 4.95 ± 0.86 (N=346) | 86.46 ± 49.00 (N=346) | |
p-value | 0.0146 | <.0001 | <.0001 | <.0001 | |
Sex | Men | 0.83 ± 1.00 (N=917) | 20.65 ± 10.26 (N=729) | 5.17 ± 1.03 (N=728) | 111.7 ± 76.35 (N=728) |
Women | 0.45 ± 0.73 (N=1228) | 18.63 ± 8.64 (N=795) | 5.13 ± 0.98 (N=795) | 99.34 ± 60.38 (N=795) | |
p-value | <.0001 | <.0001 | 0.4246 | 0.0005 | |
Race/Ethnicity | African American/Black | 0.45 ± 0.64 (N=401) | 17.94 ± 8.71 (N=264) | 5.08 ± 0.99 (N=263) | 94.77 ± 60.31 (N=263) |
White | 0.65 ± 0.88 (N=1563) | 20.03 ± 9.58 (N=1129) | 5.17 ± 1.00 (N=1 129) | 107.7 ± 69.04 (N=1 129) | |
Hispanic | 0.74 ± 1.39 (N=107) | 18.88 ± 10.11 (N=82) | 5.18 ± 1.16 (N=82) | 104.9 ± 88.25 (N=82) | |
Other/Mixed/Missing | 0.55 ± 0.87 (N=74) | 19.78 ± 9.98 (N=49) | 5.14 ± 0.87 (N=49) | 104.7 ± 63.75 (N=49) | |
p-value | 0.0002 | 0.0121 | 0.6391 | 0.0557 | |
Age | <50 years | 0.60 ± 0.94 (N=208) | 19.08 ± 8.34 (N=150) | 5.23 ± 1.00 (N=150) | 104.2 ± 64.58 (N=150) |
50 to <60 years | 0.60 ± 0.85 (N=964) | 19.60 ± 9.82 (N=695) | 5.21 ± 1.05 (N=694) | 106.9 ± 73.88 (N=694) | |
60 to <70 years | 0.64 ± 0.92 (N=811) | 19.77 ± 9.52 (N=574) | 5.09 ± 0.96 (N=574) | 104.6 ± 65.13 (N=574) | |
≥70 years | 0.52 ± 0.70 (N=162) | 19.40 ± 8.91 (N=105) | 4.95 ± 0.89 (N=105) | 99.40 ± 58.09 (N=105) | |
p-value | 0.4202 | 0.8766 | 0.0223 | 0.7435 | |
Fitness | <6 METs | 0.44 ± 0.85 (N=645) | 16.55 ± 7.51 (N=382) | 4.67 ± 0.65 (N=382) | 78.73 ± 42.87 (N=382) |
6 to <8 METs | 0.57 ± 0.73 (N=881) | 19.25 ± 8.87 (N=635) | 5.16 ± 0.93 (N=635) | 102.4 ± 61.02 (N=635) | |
8 to <10 METs | 0.79 ± 1.07 (N=435) | 21.44 ± 10.18 (N=347) | 5.39 ± 1.05 (N=346) | 119.9 ± 72.42 (N=346) | |
≥10 METs | 1.02 ± 0.91 (N=181) | 24.29 ± 11.74 (N=160) | 5.75 ± 1.34 (N=160) | 148.1 ± 102.8 (N=160) | |
p-value | <.0001 | <.0001 | <.0001 | <.0001 | |
Diabetes Medication | No Glucose Lowering Medication | 0.64 ± 0.89 (N=267) | 20.02 ± 9.57 (N=197) | 5.19 ± 1.05 (N=197) | 108.0 ± 65.55 (N=197) |
Glucose Lowering Medication (Not including insulin or thiazolidinedione) | 0.61 ± 0.89 (N=967) | 19.81 ± 9.60 (N=688) | 5.19 ± 0.98 (N=687) | 107.4 ± 68.48 (N=687) | |
Thiazolidinedione | 0.59 ± 0.75 (N=482) | 19.77 ± 9.58 (N=342) | 5.09 ± 1.04 (N=342) | 105.1 ± 72.68 (N=342) | |
Insulin Alone | 0.55 ± 0.71 (N=86) | 20.13 ± 10.31 (N=56) | 5.07 ± 1.02 (N=56) | 106.8 ± 70.93 (N=56) | |
Insulin plus glucose lowering medication (Not including thiazolidinedione) | 0.63 ± 0.86 (N=153) | 18.28 ± 8.24 (N=1 12) | 5.00 ± 0.88 (N=1 12) | 93.50 ± 51.54 (N=112) | |
Insulin plus thiazolidinedione | 0.68 ± 1.23 (N=157) | 18.28 ± 9.64 (N=111) | 5.21 ± 1.03 (N=111) | 100.5 ± 79.85 (N=111) | |
p-value | 0.8631 | 0.3827 | 0.2949 | 0.4437 | |
Cardiovascular Disease History | No | 0.61 ± 0.99 (N=329) | 19.11 ± 9.29 (N=226) | 5.03 ± 0.98 (N=226) | 99.70 ± 67.85 (N=226) |
Yes | 0.61 ± 0.85 (N=1816) | 19.68 ± 9.54 (N=1298) | 5.17 ± 1.01 (N=1297) | 106.2 ± 68.87 (N=1297) | |
p-value | 0.9854 | 0.4001 | 0.0463 | 0.1903 |
Indicates that data represent participants who reported ≥1 bout during the observation period that met the criteria of ≥3 METs per minute and ≥10 minutes for that bout.